Jim Langford has been a leader in the biopharmaceutical clinical development industry for over 25 years, where he has founded and managed several companies to leadership positions in the industry. He was the founder and President of The PHOENIX, a Contract Research Organization (CRO) that provided clinical research services to the biopharmaceutical industry, until it was sold in in 2002 to an international CRO based in Canada. While managing The PHOENIX, Jim founded an electronic data capture (EDC) software company, DataLabs, which was spun out as an independent company in 2001. DataLabs was one of the leading EDC companies at the time of its acquisition by ClinPhone, Plc. in 2006, which was subsequently acquired by PAREXEL International. In 2009, he formed a consulting company, White Star Consulting, which provides executive management services within several cell and gene therapy companies to assist them in improving their clinical development process in clinical operations, clinical logistics and how they integrate with manufacturing processes. Jim is currently the Vice President of Clinical Operations for AIVITA Biomedical where he is leading their clinical development with a dendritic cell therapy for indications in glioblastoma, ovarian cancer and metastatic melanoma.